The Inhalable Drugs Market size is expected to reach $53.6 billion in 2030 at a CAGR of 8.0%, driven by personalized medicine adoption.
Read More
The Inhalable Biologics Market size is expected to reach $6.67 billion in 2030 at a CAGR of 15.6%, driven by rising respiratory conditions.
Read More
The Influenza Vaccines Market size is expected to reach $13.13 billion in 2030 at a CAGR of 7.8%, driven by seasonal flu incidence.
Read More
The global Influenza Treatment Market size is expected to reach $8.19 billion in 2030 at a CAGR of 3.6%, driven by rising flu cases.
Read More
The global Influenza Drug market size is expected to reach $1.4 billion in 2030 at a CAGR of 5.9%, driven by rising influenza incidence.
Read More
The Inflammatory Bowel Disease Treatment market size is expected to reach $43.36 billion in 2030 at a CAGR of 9.8%, driven by IBD prevalence.
Read More
The Incretin-Based Drugs market size is expected to reach $39.25 billion in 2030 at a CAGR of 7.1%, driven by type 2 diabetes rise.
Read More
The Inactivated Vaccines market size is expected to reach $8.07 billion in 2030 at a CAGR of 5.1%, driven by infectious disease prevalence.
Read More
The Inactivated Polio And Rabies Vaccines market size is expected to reach $2.97 billion in 2030 at a CAGR of 5.5%, driven by vaccination demand.
Read More
The In Vivo Toxicology market size is expected to reach $7.79 billion in 2030 at a CAGR of 6.7%, driven by growing drug discovery activity.
Read More